Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd.
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001. Its former is a state-owned enterprise found by CNPIC of SINOPHARM. After business restructuring, it is now a rapid developing joint-stock enterprise. The sales centre of BJ Zhongshuo is located in Beijing, and responsible for selling specialized APIs and pharmaceutical intermediates both domestically and overseas. The business of BJ Zhongshuo covers more than 200 products, including the APIs and pharmaceutical intermediates related to Antivirus, Antineoplastics, Cardiovascular agents, Central Nervous System and Antibiotics, etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
Product Name: Bortezomib PS-341 CAS 179324-69-7
Alternate Name/Synonyms: MG-341; ((R)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
Description: A 10 mM (1 mg in 260 µl) solution of the proteasome inhibitor PS-341 (Cat. No. 1846) in anhydrous DMSO.
Peptide Sequence: N/A
Appearance: Liquid
Formulation: DMSO (10 mM)
CAS Number: 179324-69-7
Molecular Formula: C₁₉H₂₅BN₄O₄
Molecular Weight: 384.24
Purity: ≥99% by HPLC
Solubility:N/A
Storage Temp.: -20°C
Shipping Conditions: gel pack
Handling: Protect from moisture and light